Volpara Health Technologies (ASX:VHT), a global leader in software for the early detection of breast cancer, has signed five-year contracts with five of North America’s leading healthcare providers, representing over US$7.8M in TCV.
The new contracts include some of the US’s leading healthcare providers Bon Secours Mercy Health, Northside Hospital, Adventist Health, Duly Health and Care, and Onsite Women’s Health.
The company also announced that Centura Health, a 19-hospital health system serving patients across Colorado and western Kansas, has renewed for an additional five-years. The contract is a further US$887,000 in TCV.
Volpara is delighted to partner with such large and well- respected organisations to save even more families from cancer,” CEO Teri Thomas said.
“The growing demand for Volpara’s breast software, which brings together cancer risk assessment, density scoring, image quality optimization, and patient tracking and reporting, reflects an industry transformation to more data- driven, personalised, high-quality care.
“These new contracts are also representative of the “elephant” commercial opportunities Volpara is prioritizing to drive recurring revenue growth. The upgrades and renewals reflect the success providers rely on Volpara to deliver.”
Installation is expected to occur within the next six to 12 months. All contracts are expected to contribute to revenue growth from FY24 onwards and all contracts are for an initial five-year subscription license term with annual payments. Each customer has the right to terminate their contract after three years, except for Bon Secours Mercy Health.
